CLEANSPARK INC (CLSK) Fundamental Analysis & Valuation

NASDAQ:CLSK • US18452B2097

Current stock price

9.1 USD
+0.31 (+3.53%)
At close:
9.04 USD
-0.06 (-0.66%)
After Hours:

This CLSK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CLSK Profitability Analysis

1.1 Basic Checks

  • CLSK had negative earnings in the past year.
  • CLSK had a negative operating cash flow in the past year.
  • In the past 5 years CLSK reported 4 times negative net income.
  • CLSK had negative operating cash flow in 4 of the past 5 years.
CLSK Yearly Net Income VS EBIT VS OCF VS FCFCLSK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M -600M

1.2 Ratios

  • CLSK's Return On Assets of -8.03% is on the low side compared to the rest of the industry. CLSK is outperformed by 61.09% of its industry peers.
  • Looking at the Return On Equity, with a value of -19.32%, CLSK is in line with its industry, outperforming 40.36% of the companies in the same industry.
Industry RankSector Rank
ROA -8.03%
ROE -19.32%
ROIC N/A
ROA(3y)-4.88%
ROA(5y)-6.86%
ROE(3y)-4.21%
ROE(5y)-6.82%
ROIC(3y)N/A
ROIC(5y)N/A
CLSK Yearly ROA, ROE, ROICCLSK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200

1.3 Margins

  • The Gross Margin of CLSK (53.08%) is worse than 67.27% of its industry peers.
  • CLSK's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for CLSK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7%
GM growth 5Y21.34%
CLSK Yearly Profit, Operating, Gross MarginsCLSK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. CLSK Health Analysis

2.1 Basic Checks

  • CLSK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CLSK has more shares outstanding
  • Compared to 5 years ago, CLSK has more shares outstanding
  • Compared to 1 year ago, CLSK has a worse debt to assets ratio.
CLSK Yearly Shares OutstandingCLSK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CLSK Yearly Total Debt VS Total AssetsCLSK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • CLSK has an Altman-Z score of 1.03. This is a bad value and indicates that CLSK is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of CLSK (1.03) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.29 is on the high side and indicates that CLSK has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.29, CLSK is not doing good in the industry: 78.18% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF N/A
Altman-Z 1.03
ROIC/WACCN/A
WACC10.44%
CLSK Yearly LT Debt VS Equity VS FCFCLSK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 10.54 indicates that CLSK has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 10.54, CLSK belongs to the top of the industry, outperforming 94.18% of the companies in the same industry.
  • CLSK has a Quick Ratio of 10.54. This indicates that CLSK is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 10.54, CLSK belongs to the top of the industry, outperforming 94.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.54
Quick Ratio 10.54
CLSK Yearly Current Assets VS Current LiabilitesCLSK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. CLSK Growth Analysis

3.1 Past

  • CLSK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -237.18%.
  • Looking at the last year, CLSK shows a very strong growth in Revenue. The Revenue has grown by 67.96%.
  • CLSK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 138.17% yearly.
EPS 1Y (TTM)-237.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
Revenue 1Y (TTM)67.96%
Revenue growth 3Y79.95%
Revenue growth 5Y138.17%
Sales Q2Q%11.63%

3.2 Future

  • The Earnings Per Share is expected to decrease by -59.52% on average over the next years. This is quite bad
  • Based on estimates for the next years, CLSK will show a very strong growth in Revenue. The Revenue will grow by 21.97% on average per year.
EPS Next Y-212.49%
EPS Next 2Y-67.68%
EPS Next 3Y-59.52%
EPS Next 5YN/A
Revenue Next Year-8.23%
Revenue Next 2Y4.89%
Revenue Next 3Y21.97%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CLSK Yearly Revenue VS EstimatesCLSK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B
CLSK Yearly EPS VS EstimatesCLSK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -2 -4

More info and screens

Find the best growth stocksShow best growing peers

1

4. CLSK Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CLSK. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 92.69, the valuation of CLSK can be described as expensive.
  • CLSK's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 23.13. CLSK is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 92.69
CLSK Price Earnings VS Forward Price EarningsCLSK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLSK indicates a rather cheap valuation: CLSK is cheaper than 89.45% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.65
CLSK Per share dataCLSK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • A cheap valuation may be justified as CLSK's earnings are expected to decrease with -59.52% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-67.68%
EPS Next 3Y-59.52%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CLSK Dividend Analysis

5.1 Amount

  • CLSK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CLSK Fundamentals: All Metrics, Ratios and Statistics

CLEANSPARK INC

NASDAQ:CLSK (4/6/2026, 8:28:42 PM)

After market: 9.04 -0.06 (-0.66%)

9.1

+0.31 (+3.53%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-05
Earnings (Next)05-06
Inst Owners82.87%
Inst Owner Change0%
Ins Owners1.84%
Ins Owner Change3.86%
Market Cap2.33B
Revenue(TTM)785.19M
Net Income(TTM)-267.04M
Analysts83
Price Target20.2 (121.98%)
Short Float %34.41%
Short Ratio3.4
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.04
Dividend Growth(5Y)N/A
DP-4.17%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-290.57%
Min EPS beat(2)-478.1%
Max EPS beat(2)-103.04%
EPS beat(4)1
Avg EPS beat(4)-203.45%
Min EPS beat(4)-478.1%
Max EPS beat(4)171.26%
EPS beat(8)3
Avg EPS beat(8)6.91%
EPS beat(12)6
Avg EPS beat(12)-7.59%
EPS beat(16)7
Avg EPS beat(16)-28.99%
Revenue beat(2)0
Avg Revenue beat(2)-7.91%
Min Revenue beat(2)-8.67%
Max Revenue beat(2)-7.15%
Revenue beat(4)1
Avg Revenue beat(4)-5.68%
Min Revenue beat(4)-8.67%
Max Revenue beat(4)0.51%
Revenue beat(8)3
Avg Revenue beat(8)-2.55%
Revenue beat(12)4
Avg Revenue beat(12)-2.03%
Revenue beat(16)5
Avg Revenue beat(16)-3.78%
PT rev (1m)0%
PT rev (3m)-19%
EPS NQ rev (1m)-12.83%
EPS NQ rev (3m)-1195.1%
EPS NY rev (1m)0%
EPS NY rev (3m)-1339.76%
Revenue NQ rev (1m)-0.45%
Revenue NQ rev (3m)-25.92%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-19.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 92.69
P/S 2.96
P/FCF N/A
P/OCF N/A
P/B 1.68
P/tB 1.87
EV/EBITDA 8.65
EPS(TTM)-1.07
EYN/A
EPS(NY)0.1
Fwd EY1.08%
FCF(TTM)-2.56
FCFYN/A
OCF(TTM)-1.97
OCFYN/A
SpS3.07
BVpS5.4
TBVpS4.87
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.03%
ROE -19.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.08%
FCFM N/A
ROA(3y)-4.88%
ROA(5y)-6.86%
ROE(3y)-4.21%
ROE(5y)-6.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7%
GM growth 5Y21.34%
F-Score2
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF N/A
Debt/EBITDA 8.05
Cap/Depr 38.96%
Cap/Sales 19.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.54
Quick Ratio 10.54
Altman-Z 1.03
F-Score2
WACC10.44%
ROIC/WACCN/A
Cap/Depr(3y)67.81%
Cap/Depr(5y)346.78%
Cap/Sales(3y)33.73%
Cap/Sales(5y)94.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-237.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
EPS Next Y-212.49%
EPS Next 2Y-67.68%
EPS Next 3Y-59.52%
EPS Next 5YN/A
Revenue 1Y (TTM)67.96%
Revenue growth 3Y79.95%
Revenue growth 5Y138.17%
Sales Q2Q%11.63%
Revenue Next Year-8.23%
Revenue Next 2Y4.89%
Revenue Next 3Y21.97%
Revenue Next 5YN/A
EBIT growth 1Y-167.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-74.4%
EBIT Next 3Y-29.99%
EBIT Next 5YN/A
FCF growth 1Y-306.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-565.42%
OCF growth 3YN/A
OCF growth 5YN/A

CLEANSPARK INC / CLSK Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CLEANSPARK INC (CLSK) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CLSK.


What is the valuation status of CLEANSPARK INC (CLSK) stock?

ChartMill assigns a valuation rating of 1 / 10 to CLEANSPARK INC (CLSK). This can be considered as Overvalued.


How profitable is CLEANSPARK INC (CLSK) stock?

CLEANSPARK INC (CLSK) has a profitability rating of 1 / 10.


What is the financial health of CLEANSPARK INC (CLSK) stock?

The financial health rating of CLEANSPARK INC (CLSK) is 3 / 10.